Skip to main content

All Articles

Identifying Correct Molecular Target Essential for Treating Non–Small-Cell Lung Cancer
By Wayne Kuznar
NCCN 2017 Conference Highlights, National Comprehensive Cancer Network (NCCN)
June 2017, Vol 7, No 6
Non–small-cell lung cancer (NSCLC) comprises several different subtypes, necessitating broad molecular panel testing to understand the correct diagnosis and the appropriate treatment, said Wallace Akerley, MD, Senior Director, Community Oncology Research, Huntsman Cancer Institute, University of Utah, Salt Lake City, at the 2017 National Comprehensive Cancer Network (NCCN) annual conference. Read More ›
Medications Used for the Treatment of Melanoma (Skin Cancer) and Associated ICD-10 Codes
By Kristin A. Esposito, CPhT
Cancer Drug Coding, ICD Codes, Reimbursement, Drug Coding
June 2017, Vol 7, No 6
This detailed article of codes related to melanoma (skin cancer) is intended to assist practice managers and other healthcare providers and payers to ensure the proper use of coding and billing information associated with the treatment of patients with melanoma Read More ›
A Look at SIRT Y-90 and the SARAH Trial
A Look at SIRT Y-90 and the SARAH Trial
Videos
Dr. Valérie Vilgrain discusses SIRT Y-90 and the results of the SARAH trial. Read More ›

Page 229 of 298